Key result
Renal transplantation is linked to ~17% lower LV mass and better diastolic function at six months.
Why the study?
Renal transplantation is expected to reverse cardiac manifestations of ESRD, but large prospective echocardiographic data from India are lacking.
Does renal transplantation improve cardiac structural and functional echocardiographic parameters in patients with end-stage renal disease?
Observational (n=250)
No
Does renal transplantation improve cardiac structural and functional echocardiographic parameters in patients with end-stage renal disease?
p-value: p=<0.001
Renal transplantation produces significant and comprehensive cardiac structural and functional recovery within 6 months, with the magnitude of recovery potentially influenced by pre-transplant dialysis access type.
Supports expected cardiac recovery post-transplant in ESRD; extends observational data but leaves causal benefit and practice change open.
Introduction: Cardiovascular disease is the leading cause of mortality in end-stage renal disease (ESRD). Left ventricular hypertrophy, diastolic dysfunction and systolic impairment are the dominant cardiac manifestations of ESRD, driven by volume overload, hypertension, anaemia and uraemic toxins. Renal transplantation (KT) is expected to reverse these changes by correcting the underlying haemodynamic and metabolic drivers, yet large prospective echocardiographic data from India are lacking. Methods: Prospective observational study of 250 consecutive KT recipients at a tertiary referral centre in Rajasthan, India. Comprehensive 2D echocardiography was performed pre-transplant and at 6 months post-KT. Parameters included LV mass, LVEF, E/A ratio, E/E prime, IVS thickness, LA size and pericardial effusion. Paired t-tests and McNemar’s test were used for statistical comparisons. Results: Mean age 38.8±11.3 years; 80.4% male; 87.6% on haemodialysis pre-KT. At 6 months, all parameters improved significantly (all p<0.001): LV mass fell 16.5% (237.5 to 198.3 g); LVEF improved from 56.8% to 59.6%; E/A normalised (0.92 to 1.08); E/E prime fell from 13.64 to 10.92; diastolic dysfunction prevalence halved from 58.8% to 27.6%; pericardial effusion resolved in 66.7% of affected patients. Serum creatinine fell from 8.13 to 1.29 mg/dL confirming successful graft function. In a post-hoc exploratory analysis, dialysis access type predicted recovery magnitude: tunnelled catheter patients (n=20) showed the greatest improvement — 19.8% LV mass reduction and diastolic dysfunction resolution from 70% to 5% — while AVF patients showed the smallest gains, consistent with persistent high-output fistula loading post-KT (AVF vs DLC: delta E/E prime -1.71 vs -3.44; p=0.044). Duration of pre-transplant dialysis did not independently predict cardiac recovery (r=0.069, p=0.31). Conclusion: Successful KT produces comprehensive cardiac structural and functional recovery within 6 months — the largest prospective echocardiographic dataset from India to date. The null effect of dialysis duration is reassuring and supports early transplantation. The post-hoc access-type finding is hypothesis-generating and warrants prospective evaluation.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) conducted an observational in End-stage renal disease (ESRD) (n=250). Renal transplantation vs. Pre-transplant baseline was evaluated on Cardiac structural and functional parameters (LV mass, LVEF, E/A ratio, E/E prime, diastolic dysfunction) (p=<0.001). Renal transplantation resulted in significant cardiac recovery at 6 months, reducing LV mass by 16.5% (237.5 to 198.3 g) and decreasing diastolic dysfunction prevalence from 58.8% to 27.6% (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: